Skip to main content
menu

William B. Tabayoyong, M.D., Ph.D.

Contact Information

Phone Numbers

Appointment: (585) 275-2838

Fax: (585) 273-1068

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Locations

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 656
Rochester, NY 14642

Faculty Appointments

Patient Care Settings

Surgery, Urology

Biography

Dr. Tabayoyong is a Urologic Oncologist who specializes in both minimally invasive urologic oncology (robotic surgery of the bladder, prostate, and kidney cancers) and advanced open pelvic and retroperitoneal cancer surgery. Dr. Tabayoyong has clinical expertise in all aspects of general urology with special emphasis on the following: Bladder Cancer, Prostate Cancer, Kidney Cancer, Testicular Cancer, Penile Cancer.

Dr. Tabayoyong received his medical degree and PhD in Immunology at the University of Iowa’s Carver College of Medicine Medical Scientist Training Program at the University of Iowa in Iowa City, Iowa in 2011. He completed his urology residency at Case Western Reserve University School of Medicine in Cleveland, Ohio, in 2017. Following residency, he completed a two-year Society of Urologic Oncology fellowship at the University of Texas, MD Anderson Cancer Center in Houston, Texas, in 2019. His research interest is in Immunotherapy for urologic cancers, with primary focus on bladder cancer.

Credentials

Specialties

    Education

    2011
    MD | University Of Iowa Roy J & Lucille A Carver College Of Medicine

    Post-doctoral Training & Residency

    07/01/2017 - 06/30/2019
    Fellowship in Urologic Oncology at University of Texas MD Anderson Cancer Center

    07/01/2012 - 06/30/2017
    Residency in Urology at University Hospitals Cleveland Medical Center

    07/01/2011 - 06/30/2012
    Internship in Surgery (General Surgery) at University Hospitals Cleveland Medical Center

    VIEW ALL expand_more

    Publications

    Journal Articles

    5/16/2020
    Matulay JT, Tabayoyong W, Duplisea JJ, Chang C, Daneshmand S, Gore JL, Holzbeierlein JM, Karsh LI, Kim SP, Konety BR, Li R, McKiernan JM, Messing EM, Steinberg GD, Williams SB, Kamat AM. "Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) members." Urologic oncology.. 2020 May 16; Epub 2020 May 16.

    5/2019
    Li R, Metcalfe MJ, Tabayoyong WB, Guo CC, Nogueras González GM, Navai N, Grossman HB, Dinney CP, Kamat AM. "Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign." European urology oncology.. 2019 May; 2(3):286-293. Epub 2018 Sep 10.

    1/2019
    Li R, Tabayoyong WB, Guo CC, González GMN, Navai N, Grossman HB, Dinney CP, Kamat AM. "Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease." European urology.. 2019 Jan; 75(1):8-10. Epub 2018 Oct 06.

    Books & Chapters

    2014
    Chapter Title: Radical Prostatectomy
    Book Title: Netter's Surgical Anatomy and Approaches
    Author List: Conor P. Delaney
    Published By: Elsevier 2014 in Philadelphia, PA

    VIEW ALL PUBLICATIONS

    Videos

    play_circle_filled

    William Tabayoyong, MD, UR Medicine Urology

    Reviews

    At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information.